![Foto de ISABEL](/img/nophoto.png)
ISABEL
CAMPOS VARELA
Investigadora no período 2015-2019
Publicacións (22) Publicacións de ISABEL CAMPOS VARELA
2020
-
Does retraction after misconduct have an impact on citations? A pre-post study
BMJ Global Health, Vol. 5, Núm. 11
-
Proceedings of the 25th annual congress of the international liver transplantation society
Transplantation, Vol. 104, Núm. 8, pp. 1560-1565
-
Recipient Age for Liver Transplantation: Should It Be Limited? A Propensity Score Matching Analysis of a Large European Series
Transplantation Proceedings, Vol. 52, Núm. 5, pp. 1442-1449
-
Retraction of publications: a study of biomedical journals retracting publications based on impact factor and journal category
Gaceta Sanitaria, Vol. 34, Núm. 5, pp. 430-434
-
Temporal Trends and Outcomes in Liver Transplantation for Recipients With HIV Infection in Europe and United States
Transplantation, Vol. 104, Núm. 10, pp. 2078-2086
2019
-
Misconduct as the main cause for retraction. A descriptive study of retracted publications and their authors
Gaceta Sanitaria, Vol. 33, Núm. 4, pp. 356-360
-
Some proposals on tracking scientific misconduct
Gaceta Sanitaria
2018
-
Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study
American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522
-
Food and drinks advertising directed at children on television during reinforced protection time slot in Spain, 2017
Anales de Pediatria, Vol. 89, Núm. 3, pp. 186-187
-
Outcomes of antiviral treatment in hepatitis C virus liver transplant patients off immunosuppression in the direct acting antivirals era: A case series
Clinical Transplantation, Vol. 32, Núm. 7
-
Use of a hepatitis C virus (HCV) RNA-positive donor in a treated HCV RNA-negative liver transplant recipient
Transplant Infectious Disease, Vol. 20, Núm. 1
2017
-
Brief training in automated external defibrillation use for persons with down syndrome
Resuscitation
-
Sofosbuvir and daclatasvir in mono-and HIV-coinfected patients with recurrent hepatitis C After liver transplant
Annals of Hepatology, Vol. 16, Núm. 1, pp. 86-93
2016
-
Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma
Hepatology, Vol. 63, Núm. 2, pp. 488-498
-
Impact of cytomegalovirus infection on severe hepatitis c recurrence in patients undergoing liver transplantation
Transplantation, Vol. 100, Núm. 3, pp. 593-599
-
Key donor factors associated with graft loss among liver transplant recipients with human immunodeficiency virus
Clinical Transplantation, Vol. 30, Núm. 9, pp. 1140-1145
-
Treatment of severe recurrent hepatitis C after liver transplantation in HIV infected patients using sofosbuvir-based therapy
Alimentary Pharmacology and Therapeutics, Vol. 43, Núm. 12, pp. 1319-1329
2015
-
Advances in therapy for HIV/Hepatitis C virus-coinfected patients in the liver transplant setting
Clinical Infectious Diseases, Vol. 60, Núm. 1, pp. 108-116
-
Analysis of adult 20-year survivors after liver transplantation
Hepatology International, Vol. 9, Núm. 3, pp. 461-470
-
Doubtful role of IL28B polymorphism in occult Hepatitis B infection
Intervirology, Vol. 58, Núm. 3, pp. 160-165